Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Stabilized coronavirus spike stem elicits a broadly protective antibody
Ching‐Lin Hsieh, Anne P. Werner, Sarah R. Leist, et al.
Cell Reports (2021) Vol. 37, Iss. 5, pp. 109929-109929
Open Access | Times Cited: 82

Showing 1-25 of 82 citing articles:

Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicry
Young‐Jun Park, Anna De Marco, Tyler N. Starr, et al.
Science (2022) Vol. 375, Iss. 6579, pp. 449-454
Open Access | Times Cited: 141
Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infection
Ali Zhang, Hannah D. Stacey, Michael R. D’Agostino, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 6, pp. 381-396
Open Access | Times Cited: 126
Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease
Pan-Pan Zhou, Ge Song, Hejun Liu, et al.
Immunity (2023) Vol. 56, Iss. 3, pp. 669-686.e7
Open Access | Times Cited: 113
SARS-CoV-2 S2–targeted vaccination elicits broadly neutralizing antibodies
Kevin W. Ng, Nikhil Faulkner, Katja Finsterbusch, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 655
Open Access | Times Cited: 85
Antiviral Drug Discovery for the Treatment of COVID-19 Infections
Teresa I. Ng, Ivan Correia, Jane Seagal, et al.
Viruses (2022) Vol. 14, Iss. 5, pp. 961-961
Open Access | Times Cited: 77
Identification of a conserved S2 epitope present on spike proteins from all highly pathogenic coronaviruses
Rui P. Silva, Yimin Huang, Annalee W. Nguyen, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 64
Targetable elements in SARS-CoV-2 S2 subunit for the design of pan-coronavirus fusion inhibitors and vaccines
Liyan Guo, Sheng Lin, Zimin Chen, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 44
Opportunities and challenges in design and optimization of protein function
Dina Listov, Casper A. Goverde, Bruno E. Correia, et al.
Nature Reviews Molecular Cell Biology (2024) Vol. 25, Iss. 8, pp. 639-653
Closed Access | Times Cited: 35
Bringing immunofocusing into focus
Sriharshita Musunuri, Payton A. Weidenbacher, Peter S. Kim
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 21
Structural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunit
Nicholas K. Hurlburt, Leah J. Homad, Irika Sinha, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 66
Structure-based design of stabilized recombinant influenza neuraminidase tetramers
Daniel Ellis, Julia Lederhofer, Oliver J. Acton, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 45
The role of vaccines in the COVID-19 pandemic: what have we learned?
Florian Krammer
Seminars in Immunopathology (2023) Vol. 45, Iss. 4-6, pp. 451-468
Open Access | Times Cited: 38
High-affinity, neutralizing antibodies to SARS-CoV-2 can be made without T follicular helper cells
Jennifer Chen, Ryan D. Chow, Eric Song, et al.
Science Immunology (2022) Vol. 7, Iss. 68
Open Access | Times Cited: 37
SARS-CoV-2 spike S2-specific neutralizing antibodies
Chia‐Jung Li, Shih‐Chung Chang
Emerging Microbes & Infections (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 33
Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challenge
Ching‐Lin Hsieh, Sarah R. Leist, Emily Happy Miller, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Mapping immunodominant sites on the MERS-CoV spike glycoprotein targeted by infection-elicited antibodies in humans
Amin Addetia, Cameron Stewart, Albert J. Seo, et al.
Cell Reports (2024) Vol. 43, Iss. 8, pp. 114530-114530
Open Access | Times Cited: 8
Principles and practical applications of structure-based vaccine design
Patrick O. Byrne, Jason S. McLellan
Current Opinion in Immunology (2022) Vol. 77, pp. 102209-102209
Open Access | Times Cited: 34
Structure-based neutralizing mechanisms for SARS-CoV-2 antibodies
Qingrui Huang, Xiaonan Han, Jinghua Yan
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 2412-2422
Open Access | Times Cited: 30
Receptor-Binding Domain (RBD) Antibodies Contribute More to SARS-CoV-2 Neutralization When Target Cells Express High Levels of ACE2
Ariana Ghez Farrell, Bernadeta Dadonaite, Allison J. Greaney, et al.
Viruses (2022) Vol. 14, Iss. 9, pp. 2061-2061
Open Access | Times Cited: 29
Structural insights into the modulation of coronavirus spike tilting and infectivity by hinge glycans
David Chmielewski, Eric Wilson, Grigore Pintilie, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 15
A broadly generalizable stabilization strategy for sarbecovirus fusion machinery vaccines
Jimin Lee, Cameron Stewart, Alexandra Schäfer, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Protective non-neutralizing SARS-CoV-2 monoclonal antibodies
Arman Izadi, Pontus Nordenfelt
Trends in Immunology (2024) Vol. 45, Iss. 8, pp. 609-624
Open Access | Times Cited: 6
Mapping immunodominant sites on the MERS-CoV spike glycoprotein targeted by infection-elicited antibodies in humans
Amin Addetia, Cameron Stewart, Albert J. Seo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
Simulation-driven design of stabilized SARS-CoV-2 spike S2 immunogens
Xandra Nuqui, Lorenzo Casalino, Ling Zhou, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Discovery and characterization of a pan-betacoronavirus S2-binding antibody
Nicole V. Johnson, Steven C. Wall, Kevin J. Kramer, et al.
Structure (2024)
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top